Botulinum Toxin Type A for Therapeutic Use from Japan
Purified botulinum toxin type A complex, indicated for cervical dystonia and spasticity management. Falls under HTS 3002.90.52.50 as a toxin prepared for therapeutic use, a culture-derived product modulating neuromuscular transmission. Used in measured doses for neurological conditions.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include potency bioassay results in LD50 units for FDA clearance
• Refrigerated transport required; monitor for 2-8°C compliance
• Distinguish from cosmetic uses which may fall under medicaments